Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glial Cells01:04

Glial Cells

Overview
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Nervous Tissue: Glial Cells01:31

Nervous Tissue: Glial Cells

Glia, or neuroglia, are vital support cells that assist neurons in their functions. The term "glia" originates from the Greek word for "glue," reflecting their role in holding the nervous system together. These cells can be categorized into six types: four in the central nervous system (CNS) and two in the peripheral nervous system (PNS).
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial cells that interact...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bridging the gap between tumor and disease: Innovating cancer and glioma models.

The Journal of experimental medicine·2024
Same author

DOTATATE PET/MR Imaging Differentiates Secondary-Progressive from de Novo World Health Organization Grade 3 Meningiomas.

AJNR. American journal of neuroradiology·2024
Same author

Stem cell modeling of nervous system tumors.

Disease models & mechanisms·2024
Same author

Microenvironment-Driven Dynamic Chromatin Changes in Glioblastoma Recapitulate Early Neural Development at Single-Cell Resolution.

Cancer research·2023
Same author

Nuclear condensates in YAP1-driven ependymoma.

Nature cell biology·2023
Same author

Reirradiation for Recurrent Glioblastoma: What We Know and What We Do Not.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2022

Related Experiment Video

Updated: May 11, 2026

Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry
12:25

Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry

Published on: January 7, 2014

15.2K

Glioblastoma: Not Just Another Cancer.

Howard A Fine1

  • 1Department of Neurology, Meyer Cancer Center, Weill Cornell Medicine, New York, New York.

Cancer Discovery
|April 4, 2024
PubMed
Summary
This summary is machine-generated.

Glioblastoma research needs a new approach, viewing it as a unique brain-like organ. This perspective aims to drive innovative treatments and collaboration for better patient survival outcomes.

More Related Videos

Co-culture of Glioblastoma Stem-like Cells on Patterned Neurons to Study Migration and Cellular Interactions
10:08

Co-culture of Glioblastoma Stem-like Cells on Patterned Neurons to Study Migration and Cellular Interactions

Published on: February 24, 2021

5.9K
Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

2.7K

Related Experiment Videos

Last Updated: May 11, 2026

Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry
12:25

Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry

Published on: January 7, 2014

15.2K
Co-culture of Glioblastoma Stem-like Cells on Patterned Neurons to Study Migration and Cellular Interactions
10:08

Co-culture of Glioblastoma Stem-like Cells on Patterned Neurons to Study Migration and Cellular Interactions

Published on: February 24, 2021

5.9K
Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

2.7K

Area of Science:

  • Neuro-oncology
  • Cancer Biology
  • Translational Medicine

Background:

  • Glioblastoma (GBM) research has seen minimal progress in extending patient survival.
  • Existing cancer research paradigms may not be optimal for understanding and treating GBM.
  • Significant investment has yielded limited therapeutic advancements.

Purpose of the Study:

  • To propose a paradigm shift in glioblastoma research and drug development.
  • To reframe glioblastoma as an aberrant brain-like organ.
  • To foster innovative treatment strategies and interdisciplinary collaboration.

Main Methods:

  • Conceptual analysis and synthesis of current glioblastoma research.
  • Reimagining glioblastoma within a neurobiological framework.
  • Advocating for a shift in research focus and collaborative models.

Main Results:

  • A novel conceptual framework for glioblastoma research.
  • Identification of potential new avenues for therapeutic development.
  • Emphasis on the need for interdisciplinary approaches.

Conclusions:

  • Treating glioblastoma as a unique brain-like organ is crucial for future progress.
  • This shift can inspire novel therapeutic strategies and enhance collaborative efforts.
  • A new research paradigm is essential to overcome current limitations in glioblastoma treatment.